Sung Ku Kang

Sung Ku Kang

Auto-generated profile, based on publicly available information

Sung Ku Kang

Department of Urology, National Health Insurance Service Ilsan Hospital, Goyang, Korea

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Medicine
Verified
Journal Article
Open access
PDF file
SKSung Ku Kang
Sung Ku Kang
KCKang Su Cho
Kang Su Cho
DKDong Hyuk Kang
Dong Hyuk Kang
HJHae Do Jung
Hae Do Jung
JKJong Kyou Kwon
Jong Kyou Kwon
Joo Yong LeeJoo Yong Lee
Joo Yong Lee
We performed a systematic review and meta-analysis comparing stone-free rates between retrograde intrarenal surgery (RIRS) and percutaneous nephrolithotomy (PCNL), using updated, more reliable evidence. Randomized controlled trials comparing RIRS and PCNL for >2 cm stones were identified from electronic databases. Stone-free rates for the procedures were compared by qualitative and quantitative syntheses (meta-analyses). Outcome variables are shown as risk ratios (RRs) with 95% confidence intervals (CIs). Eleven articles were included in this study. Most recently published studies exhibited relatively low quality during quality assessment. For the meta-analysis comparing success (stone-free) rates between PCNL and RIRS, the forest plot using the random-effects model showed an RR of 1.11 (95% CI 1.02–1.21, P < .014) favoring PCNL. After determining the among-study heterogeneity, subgroup analysis was performed of 9 studies with less heterogeneity: the stone-free rate of PCNL was superior to that of RIRS using a fixed-effect model (RR 1.07, 95% CI 1.01–1.14, P < .019) for these studies. RIRS can be a safe and effective procedure for selected patients with large renal stones. However, in this meta-analysis, the postoperative stone-free rate of PCNL was higher than that of RIRS in patients with >2 cm renal stones.

1 January 2019 in Investigative and Clinical Urology
Verified
Journal Article
Open access
JHJi Eun Heo
Ji Eun Heo
SKSung Ku Kang
Sung Ku Kang
DKDong Hoon Koh
Dong Hoon Koh
JNJoon Chae Na
Joon Chae Na
YLYong Seung Lee
Yong Seung Lee
WJWon Sik Jang
Won Sik Jang
Laparoendoscopic single-site surgery (LESS) reduces the limited invasiveness of conventional laparoscopy while providing superior cosmetic results. However, LESS remains a challenging surgical technique, even in robotic surgery, primarily due to the lack of triangulation and limited instrument movement. The da Vinci SP surgical system (Intuitive Surgical) was recently introduced to overcome these limitations. We describe our initial experience with pure single-site robot-assisted pyeloplasty (RAP) for ureteropelvic junction obstruction (UPJO) using the da Vinci SP surgical system. Three consecutive patients who were diagnosed with UPJO underwent RAP with the da Vinci SP surgical system from December 2018 to February 2019 at our institution. The surgical technique involved reproducing the steps of multi-port RAP. A 30-mm umbilical incision was made and the GelPOINT was inserted. The multichannel robotic port and the assistant's port were placed through the GelSeal cap. In all patients, Anderson-Hynes dismembered pyeloplasty was performed. The ureteral double J stent was inserted antegrade, and the drain was not placed. The procedures were successfully completed using a pure single-site approach. There was no need for additional port placement or conversion to laparoscopic or open surgery. Total operative time in the three patients was 139, 180, and 213 minutes, respectively. No intraoperative complications occurred, and blood loss was minimal. The postoperative course of all patients was uneventful with no complications greater than Clavien-Dindo grade I surgical complications. Pure single-site RAP using the da Vinci SP surgical system is feasible and safe.

1 January 2021 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
SKSung Ku Kang
Sung Ku Kang
WJWon Sik Jang
Won Sik Jang
SKSung Hoon Kim
Sung Hoon Kim
SKSang Woon Kim
Sang Woon Kim
SHSang Won Han
Sang Won Han
YLYong Seung Lee
Yong Seung Lee
Kang SK, et al. Investig Clin Urol. 2021 Jul;62:e60. https://doi.org/10.4111/icu.20200569

1 October 2019 in Journal of Pediatric Urology
Verified
Journal Article
Closed access
SKSung Ku Kang
Sung Ku Kang
WJWon Sik Jang
Won Sik Jang
SKSang Woon Kim
Sang Woon Kim
SKSung Hoon Kim
Sung Hoon Kim
SHSang Won Han
Sang Won Han
YLYong Seung Lee
Yong Seung Lee

1 June 2023 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
JHJi Eun Heo
Ji Eun Heo
SKSung Ku Kang
Sung Ku Kang
JLJongsoo Lee
Jongsoo Lee
DKDonghoon Koh
Donghoon Koh
MKMin Seok Kim
Min Seok Kim
WJWon Sik Jang
Won Sik Jang
Heo JE, et al. Investig Clin Urol. 2023 Jun;64:e42. https://doi.org/10.4111/icu.20230005

1 June 2017 in Transplantation Proceedings
Verified
Journal Article
Closed access
HLH.H. Lee
H.H. Lee
SKS.K. Kang
S.K. Kang
YYY.E. Yoon
Y.E. Yoon
KHKyu Ha Huh
Kyu Ha Huh
MKM.S. Kim
M.S. Kim
WHWoong Kyu Han
Woong Kyu Han